US Stock MarketDetailed Quotes

APGE Apogee Therapeutics

Watchlist
  • 44.700
  • +0.740+1.68%
Close Nov 27 16:00 ET
  • 44.700
  • 0.0000.00%
Post 20:01 ET
2.62BMarket Cap-17339P/E (TTM)

Apogee Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
141.46%58.69M
133.64%44.12M
201.64%38.18M
202.68%93M
163.53%37.16M
131.32%24.31M
939.92%18.89M
12.66M
30.73M
14.1M
Selling and administrative expenses
79.27%12.97M
121.02%10.92M
125.20%9.47M
735.74%24.58M
333.69%8.2M
1,063.34%7.24M
1,242.12%4.94M
--4.2M
--2.94M
--1.89M
-General and administrative expense
79.27%12.97M
121.02%10.92M
125.20%9.47M
735.74%24.58M
333.69%8.2M
1,063.34%7.24M
1,242.12%4.94M
--4.2M
--2.94M
--1.89M
Research and development costs
167.82%45.71M
138.10%33.21M
239.63%28.72M
146.25%68.42M
137.17%28.95M
72.68%17.07M
863.12%13.95M
--8.46M
--27.79M
--12.21M
Operating profit
-141.46%-58.69M
-133.64%-44.12M
-201.64%-38.18M
-202.68%-93M
-163.53%-37.16M
-131.32%-24.31M
-939.92%-18.89M
-12.66M
-30.73M
-14.1M
Net non-operating interest income expense
179.02%9.67M
10.31M
4,476.69%6.09M
199.56%9.02M
5,791.30%5.42M
137.87%3.47M
0
133K
-9.06M
92K
Non-operating interest income
179.02%9.67M
--10.31M
4,476.69%6.09M
9,702.17%9.02M
5,791.30%5.42M
--3.47M
--0
--133K
--92K
--92K
Non-operating interest expense
----
----
----
--0
----
----
----
----
--9.15M
--0
Other net income (expense)
Income before tax
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
-111.10%-83.99M
-126.57%-31.74M
-6.02%-20.84M
-939.92%-18.89M
-12.53M
-39.79M
-14.01M
Income tax
Net income
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
-111.10%-83.99M
-126.57%-31.74M
-6.02%-20.84M
-939.92%-18.89M
-12.53M
-39.79M
-14.01M
Net income continuous Operations
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
-111.10%-83.99M
-126.57%-31.74M
-6.02%-20.84M
-939.92%-18.89M
---12.53M
---39.79M
---14.01M
Minority interest income
Net income attributable to the parent company
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
-111.10%-83.99M
-126.57%-31.74M
-6.02%-20.84M
-939.92%-18.89M
-12.53M
-39.79M
-14.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
-111.10%-83.99M
-126.57%-31.74M
-6.02%-20.84M
-939.92%-18.89M
-12.53M
-39.79M
-14.01M
Basic earnings per share
-68.63%-0.86
-51.28%-0.6
-39.23%-0.64
-130.11%-3.36
-27.23%-0.6541
94.61%-0.51
-495.07%-0.3966
-0.4597
-1.4602
-0.5141
Diluted earnings per share
-68.63%-0.86
-51.28%-0.6
-39.23%-0.64
-130.11%-3.36
-27.23%-0.6541
94.61%-0.51
-495.07%-0.3966
-0.4597
-1.4602
-0.5141
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 141.46%58.69M133.64%44.12M201.64%38.18M202.68%93M163.53%37.16M131.32%24.31M939.92%18.89M12.66M30.73M14.1M
Selling and administrative expenses 79.27%12.97M121.02%10.92M125.20%9.47M735.74%24.58M333.69%8.2M1,063.34%7.24M1,242.12%4.94M--4.2M--2.94M--1.89M
-General and administrative expense 79.27%12.97M121.02%10.92M125.20%9.47M735.74%24.58M333.69%8.2M1,063.34%7.24M1,242.12%4.94M--4.2M--2.94M--1.89M
Research and development costs 167.82%45.71M138.10%33.21M239.63%28.72M146.25%68.42M137.17%28.95M72.68%17.07M863.12%13.95M--8.46M--27.79M--12.21M
Operating profit -141.46%-58.69M-133.64%-44.12M-201.64%-38.18M-202.68%-93M-163.53%-37.16M-131.32%-24.31M-939.92%-18.89M-12.66M-30.73M-14.1M
Net non-operating interest income expense 179.02%9.67M10.31M4,476.69%6.09M199.56%9.02M5,791.30%5.42M137.87%3.47M0133K-9.06M92K
Non-operating interest income 179.02%9.67M--10.31M4,476.69%6.09M9,702.17%9.02M5,791.30%5.42M--3.47M--0--133K--92K--92K
Non-operating interest expense --------------0------------------9.15M--0
Other net income (expense)
Income before tax -135.21%-49.02M-79.06%-33.82M-156.24%-32.09M-111.10%-83.99M-126.57%-31.74M-6.02%-20.84M-939.92%-18.89M-12.53M-39.79M-14.01M
Income tax
Net income -135.21%-49.02M-79.06%-33.82M-156.24%-32.09M-111.10%-83.99M-126.57%-31.74M-6.02%-20.84M-939.92%-18.89M-12.53M-39.79M-14.01M
Net income continuous Operations -135.21%-49.02M-79.06%-33.82M-156.24%-32.09M-111.10%-83.99M-126.57%-31.74M-6.02%-20.84M-939.92%-18.89M---12.53M---39.79M---14.01M
Minority interest income
Net income attributable to the parent company -135.21%-49.02M-79.06%-33.82M-156.24%-32.09M-111.10%-83.99M-126.57%-31.74M-6.02%-20.84M-939.92%-18.89M-12.53M-39.79M-14.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -135.21%-49.02M-79.06%-33.82M-156.24%-32.09M-111.10%-83.99M-126.57%-31.74M-6.02%-20.84M-939.92%-18.89M-12.53M-39.79M-14.01M
Basic earnings per share -68.63%-0.86-51.28%-0.6-39.23%-0.64-130.11%-3.36-27.23%-0.654194.61%-0.51-495.07%-0.3966-0.4597-1.4602-0.5141
Diluted earnings per share -68.63%-0.86-51.28%-0.6-39.23%-0.64-130.11%-3.36-27.23%-0.654194.61%-0.51-495.07%-0.3966-0.4597-1.4602-0.5141
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data